The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.50
Bid: 39.00
Ask: 40.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.564%)
Open: 39.50
High: 39.50
Low: 39.50
Prev. Close: 39.50
VEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

F-1 Third Amendment Announcement

19 Oct 2010 07:00

RNS Number : 5937U
Velti PLC
19 October 2010
 



 

For Immediate Release October 19, 2010

Velti Plc

("Velti" or the "Company")

 

Velti Files Third Amendment to Form F-1

Dublin, Ireland and San Francisco, CA - Velti plc ('Velti' or 'the Company'), a leading mobile marketing and advertising technology provider for brands, advertising agencies, mobile operators and media, today announced that it has filed a third amendment to its registration statement on Form F-1 previously filed with the United States Securities and Exchange Commission for a proposed initial public offering of its ordinary shares.

Jefferies & Company, Inc. will act as sole book-running manager for the offering with RBC Capital Markets Corporation and Needham & Company, LLC acting as co-lead managers, and ThinkEquity LLC and Cannacord Genuity acting as co-managers. The ordinary shares to be sold in this offering are proposed to be sold by Velti plc and certain of Velti's shareholders. The number of ordinary shares to be sold in the proposed offering and the offering price has not yet been determined.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering will be made only by means of a prospectus.

A copy of the registration statement can be accessed through the Securities and Exchange Commission's web site at www.sec.gov. A written preliminary prospectus related to the offering may be obtained, when available, from the prospectus department of:

Jefferies & Company, Inc., Equity Syndicate Middle Office, Attn: Stephen M. Ficara, 520 Madison Avenue, 12th Floor, New York, NY 10022 (telephone: 212-284-3418/email: sficara@jefferies.com)

END

For further information, please contact:

 
Bankside Consultants
Simon Bloomfield simon.bloomfield@bankside.com
+44 (0) 207 367 8861
 
The Blueshirt Group
Mike Bishop
mike@blueshirtgroup.com
+1 (415) 217 4968
 
RBC Capital Markets
(NOMAD and Broker)
Joshua Critchley
Matthew Coakes
Brett Jacobs
+44 (0) 207 653 4000
 
Velti plc
Alex Moukas
Chief Executive Officer
+1 (415) 315 3400
 
Wilson Cheung
Chief Financial Officer
+1 (415) 315 3480
 
Dakota Sullivan
VP, Global Marketing
dsullivan@velti.com
+1 (415) 315 3436

About Velti

Velti is a provider of mobile marketing and advertising solutions that enable brands, advertising agencies, mobile operators and media to implement campaigns by communicating with and engaging consumers via their mobile devices. Velti is a publicly-held corporation based in Jersey and trades on the London Stock Exchange's AIM under the symbol VEL.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWOARRSARAUA
Date   Source Headline
12th Jan 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
11th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20229:14 amRNSHolding(s) in Company
20th Dec 20222:05 pmRNSSecond Price Monitoring Extn
20th Dec 20222:00 pmRNSPrice Monitoring Extension
20th Dec 202211:05 amRNSSecond Price Monitoring Extn
20th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20229:05 amRNSSecond Price Monitoring Extn
20th Dec 20229:00 amRNSPrice Monitoring Extension
20th Dec 20227:01 amRNSTrading Update & Notice of Results
20th Dec 20227:00 amRNSUS $100M GKN Agreement
15th Nov 20223:09 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSDirectorate Change
11th Oct 20227:00 amRNSDirectorate Change
7th Oct 20227:00 amRNSExercise of Share Options and Issue of Equity
29th Jun 20227:00 amRNSUnaudited Half Year Results
23rd Jun 20227:00 amRNSInvestor Presentation
9th Jun 20223:31 pmRNSDirectorate Change
8th Jun 20227:00 amRNSDirectorate Change
24th May 20227:00 amRNSTrading Update and Notice of Results
7th Apr 20227:00 amRNSDirector/PDMR Shareholding
29th Mar 20225:30 pmRNSExercise of Share Options and Issue of Equity
29th Mar 20223:52 pmRNSDirectorate Change and Grant of Options
17th Mar 202210:57 amRNSGrant of Share Options
1st Mar 20223:45 pmRNSResults of Annual General Meeting
26th Jan 20227:00 amRNSPublication of Annual Report and Notice of AGM
24th Jan 20227:00 amRNSFinal Results
17th Jan 20227:00 amRNSInvestor Presentation
1st Dec 20217:00 amRNSTrading Update & Notice of Results
28th Sep 202112:14 pmRNSHolding(s) in Company
15th Sep 20212:25 pmRNSDirectorate Change
30th Jul 202110:02 amRNSHolding(s) in Company
1st Jul 20212:28 pmRNSHolding(s) in Company
30th Jun 20217:00 amRNSHalf-year Report
17th Jun 20217:00 amRNSInvestor Presentation
28th May 20214:30 pmRNSTotal Voting Rights
25th May 20218:30 amRNSIssue of Equity
24th May 20217:00 amRNSTrading Statement
14th May 20212:05 pmRNSSecond Price Monitoring Extn
14th May 20212:00 pmRNSPrice Monitoring Extension
14th May 20217:00 amRNSContract
1st Apr 202110:15 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSThree Year Contract Extension
23rd Feb 20214:14 pmRNSResult of AGM
10th Feb 20215:56 pmRNSDirector/PDMR Shareholding
9th Feb 20219:00 amRNSIssue of Equity
2nd Feb 20212:30 pmRNSContract
26th Jan 20217:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.